SG Americas Securities
TSHA icon

SG Americas Securities’s Taysha Gene Therapies TSHA Stock Holding History

SG Americas Securities’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.73M Buy
2,176,742
+1,395,268
+179% +$6.49M 0.01% 799
2025
Q4 		$4.3M Buy
781,474
+748,525
+2,272% +$3.63M 0.01% 1151
2025
Q3 		$108K Sell
32,949
-460,352
-93% -$1.3M ﹤0.01% 3051
2025
Q2 		$1.14M Buy
+493,301
New +$1.07M ﹤0.01% 1092
2025
Q1 		– Sell
-28,498
Closed -$49K – 3768
2024
Q4 		$49K Sell
28,498
-35,486
-55% -$73.6K ﹤0.01% 2910
2024
Q3 		$129K Buy
+63,984
New +$140K ﹤0.01% 2848
2021
Q4 		– Sell
-9,168
Closed -$171K – 3811
2021
Q3 		$171K Buy
+9,168
New +$174K ﹤0.01% 3337

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM